Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Operating Expenses: 2013-2020

Historic Operating Expenses for Larimar Therapeutics (LRMR) over the last 6 years, with Mar 2020 value amounting to $3.6 million.

  • Larimar Therapeutics' Operating Expenses fell 73.16% to $3.6 million in Q1 2020 from the same period last year, while for Mar 2020 it was $35.9 million, marking a year-over-year decrease of 38.77%. This contributed to the annual value of $45.7 million for FY2019, which is 25.31% down from last year.
  • As of Q1 2020, Larimar Therapeutics' Operating Expenses stood at $3.6 million, which was down 51.06% from $7.3 million recorded in Q4 2019.
  • Over the past 5 years, Larimar Therapeutics' Operating Expenses peaked at $17.9 million during Q1 2016, and registered a low of $3.6 million during Q1 2020.
  • Over the past 3 years, Larimar Therapeutics' median Operating Expenses value was $13.3 million (recorded in 2019), while the average stood at $12.3 million.
  • Per our database at Business Quant, Larimar Therapeutics' Operating Expenses spiked by 34.87% in 2016 and then crashed by 73.16% in 2020.
  • Over the past 5 years, Larimar Therapeutics' Operating Expenses (Quarterly) stood at $10.5 million in 2016, then increased by 27.52% to $13.4 million in 2017, then grew by 9.98% to $14.7 million in 2018, then crashed by 50.44% to $7.3 million in 2019, then tumbled by 73.16% to $3.6 million in 2020.
  • Its Operating Expenses stands at $3.6 million for Q1 2020, versus $7.3 million for Q4 2019 and $12.9 million for Q3 2019.